<DOC>
	<DOCNO>NCT01445873</DOCNO>
	<brief_summary>The objective study develop research method correspond material study effectiveness sitaxentan sodium ( Thelin ) `` real-world '' setting ; pilot test method three study center Europe ; refine finalize research method correspond material possible use follow-on , full-scale examination effectiveness sitaxentan sodium ( Thelin ) `` real-world '' setting .</brief_summary>
	<brief_title>Pilot Chart Review Study Of Sitaxentan Sodium ( Thelin ) In Patients With Pulmonary Arterial Hypertension ( PAH )</brief_title>
	<detailed_description>At centre , approximately 12-15 Pulmonary Arterial Hypertension ( PAH ) consecutive patient receive Thelin meet study entry criterion .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Familial Primary Pulmonary Hypertension</mesh_term>
	<mesh_term>Sitaxsentan</mesh_term>
	<criteria>Idiopathic PAH , PAH secondary connective tissue disease Receipt Thelin treatment PAH 6 month followup ( except event death ) subsequent initial receipt Thelin Minimum one clinic visit document medical record 6month period subsequent initial receipt Thelin Participation investigational study Thelin medication treatment PAH period begin 6 month prior initial receipt Thelin end 6 month subsequent receipt Receipt Thelin prior January 11 , 2005 ( i.e. , date follow last day patient could enrol doubleblind treatment STRIDE1 , STRIDE2 , and/or STRIDE6 ) ; Known contraindication Thelin therapy ( i.e. , know hypersensitivity sitaxsentan excipients ; mildtosevere hepatic impairment [ ChildPugh Class AC ] ; elevate aminotransferase prior initiation treatment , define aspartate aminotransferase [ AST ] and/or alanine aminotransferase [ ALT ] &gt; 3 time upper limit normal [ ULN ] ; concomitant use cyclosporin A ; lactation )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2011</verification_date>
	<keyword>Pulmonary arterial hypertension</keyword>
	<keyword>sitaxentan sodium</keyword>
	<keyword>Thelin</keyword>
</DOC>